Tampa, Fla.-based Moffitt Cancer Center has opened an outpatient facility on its Land O’ Lakes, Fla.-based research and medical campus, Speros. The Moffitt Speros Outpatient Center is also home to the Richard M. Schulze Family Foundation Proton Therapy Center, according…
The Latest
Atara Biotherapeutics received a second complete response letter from the FDA for its biologics license application for Ebvallo (tabelecleucel). The letter, received Jan. 9, said the FDA no longer considers the single-arm ALLELE trial adequate to support accelerated approval for…
The FDA has updated guidance outlining how it applies regulatory flexibility to chemistry, manufacturing and control requirements for cell and gene therapies. The agency said the approach is meant to expedite development of complex biologics without compromising safety, purity or…
Breakthroughs in cancer research continue to emerge from academic medical centers, with recent studies finding new ways to target tumors, guide treatment decisions and improve immunotherapy effectiveness. From nanoparticles to genetic discoveries, here are five recent breakthroughs from cancer researchers…
Detroit-based Henry Ford Health has formed a joint venture with BAMF Health to expand access to precision diagnostics and treatment for patients in the region. Under the partnership, the organizations will establish a 45,000-square-foot comprehensive theranostics center in downtown Detroit.…
Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing one of the first double lung-liver transplants in the U.S., eliminating all traces of colorectal cancer for a terminal patient through a liver transplant, providing…
About 7.5 million Medicaid-enrolled adults may lose coverage for cancer screening within the first two years after implementation of the 2025 Budget Reconciliation Bill, according to a study published Jan. 8 in JAMA Oncology. The 2025 Budget Reconciliation Bill —…
New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, called PRISM, uses an oncology-specific large language model…
Philadelphia based-Fox Chase Cancer Center has launched a partnership with Arima Genomics to strengthen diagnostic capabilities in clinical practice through 3D genomic sequencing and analysis. The Cancer Epigenetics Institute at Fox Chase will incorporate Arima’s technology in its diagnostic workflows…
Little Rock-based University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has invested $2.4 million in Advarra’s clinical trial management system to expand its clinical trial capabilities. The Cancer Institute and the UAMS Translational Research Institute are using…